LOCUS       NP_000730                466 aa                     PRI 03-MAY-2014
DEFINITION  muscarinic acetylcholine receptor M2 [Homo sapiens].
ACCESSION   NP_000730
VERSION     NP_000730.1  GI:4502817
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 466)
  AUTHORS   Hou D, Chen Y, Liu J, Xu L, Zhang Z, Zhang J, Wang H, Wang X, Chen
            J, Zhao R, Hu A, Hakonarson H, Zhang L and Shen Y.
  TITLE     Proteomics screen to reveal molecular changes mediated by C722G
            missense mutation in CHRM2 gene
  JOURNAL   J Proteomics 89, 39-50 (2013)
   PUBMED   23743182
  REMARK    GeneRIF: This novel study demonstrated for the first time a
            full-scale screening of the proteomics research by CHRM2-C722G
            mutation and profiled 102 changed proteins, of which, eight might be
            critical in cardiac dysfunction
REFERENCE   2  (residues 1 to 466)
  AUTHORS   Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G,
            Kallela M, Malik R, de Vries B, Terwindt G, Medland SE, Todt U,
            McArdle WL, Quaye L, Koiranen M, Ikram MA, Lehtimaki T, Stam AH,
            Ligthart L, Wedenoja J, Dunham I, Neale BM, Palta P, Hamalainen E,
            Schurks M, Rose LM, Buring JE, Ridker PM, Steinberg S, Stefansson H,
            Jakobsson F, Lawlor DA, Evans DM, Ring SM, Farkkila M, Artto V,
            Kaunisto MA, Freilinger T, Schoenen J, Frants RR, Pelzer N, Weller
            CM, Zielman R, Heath AC, Madden PA, Montgomery GW, Martin NG, Borck
            G, Gobel H, Heinze A, Heinze-Kuhn K, Williams FM, Hartikainen AL,
            Pouta A, van den Ende J, Uitterlinden AG, Hofman A, Amin N, Hottenga
            JJ, Vink JM, Heikkila K, Alexander M, Muller-Myhsok B, Schreiber S,
            Meitinger T, Wichmann HE, Aromaa A, Eriksson JG, Traynor BJ,
            Trabzuni D, Rossin E, Lage K, Jacobs SB, Gibbs JR, Birney E, Kaprio
            J, Penninx BW, Boomsma DI, van Duijn C, Raitakari O, Jarvelin MR,
            Zwart JA, Cherkas L, Strachan DP, Kubisch C, Ferrari MD, van den
            Maagdenberg AM, Dichgans M, Wessman M, Smith GD, Stefansson K, Daly
            MJ, Nyholt DR, Chasman DI and Palotie A.
  CONSRTM   North American Brain Expression Consortium; UK Brain Expression
            Consortium; International Headache Genetics Consortium
  TITLE     Genome-wide meta-analysis identifies new susceptibility loci for
            migraine
  JOURNAL   Nat. Genet. 45 (8), 912-917 (2013)
   PUBMED   23793025
REFERENCE   3  (residues 1 to 466)
  AUTHORS   Miao Y, Nichols SE, Gasper PM, Metzger VT and McCammon JA.
  TITLE     Activation and dynamic network of the M2 muscarinic receptor
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 110 (27), 10982-10987 (2013)
   PUBMED   23781107
  REMARK    GeneRIF: Activation occurs by formation of a Tyr206-Tyr440 hydrogen
            bond and 6A outward tilting of the cytoplasmic end of transmembrane
            alpha-helix 6, preceded by relocation of Trp400 toward Phe195 and
            Val199 and flipping of Tyr430 away from the ligand-binding cavity.
REFERENCE   4  (residues 1 to 466)
  AUTHORS   Oenema TA, Mensink G, Smedinga L, Halayko AJ, Zaagsma J, Meurs H,
            Gosens R and Dekkers BG.
  TITLE     Cross-talk between transforming growth factor-beta(1) and muscarinic
            M(2) receptors augments airway smooth muscle proliferation
  JOURNAL   Am. J. Respir. Cell Mol. Biol. 49 (1), 18-27 (2013)
   PUBMED   23449734
  REMARK    GeneRIF: Muscarinic M2 receptor stimulation enhances
            TGF-beta1-induced airway smooth muscle cell proliferation.
REFERENCE   5  (residues 1 to 466)
  AUTHORS   den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM,
            Nolte IM, Segre AV, Holm H, Handsaker RE, Westra HJ, Johnson T,
            Isaacs A, Yang J, Lundby A, Zhao JH, Kim YJ, Go MJ, Almgren P,
            Bochud M, Boucher G, Cornelis MC, Gudbjartsson D, Hadley D, van der
            Harst P, Hayward C, den Heijer M, Igl W, Jackson AU, Kutalik Z, Luan
            J, Kemp JP, Kristiansson K, Ladenvall C, Lorentzon M, Montasser ME,
            Njajou OT, O'Reilly PF, Padmanabhan S, St Pourcain B, Rankinen T,
            Salo P, Tanaka T, Timpson NJ, Vitart V, Waite L, Wheeler W, Zhang W,
            Draisma HH, Feitosa MF, Kerr KF, Lind PA, Mihailov E, Onland-Moret
            NC, Song C, Weedon MN, Xie W, Yengo L, Absher D, Albert CM, Alonso
            A, Arking DE, de Bakker PI, Balkau B, Barlassina C, Benaglio P, Bis
            JC, Bouatia-Naji N, Brage S, Chanock SJ, Chines PS, Chung M, Darbar
            D, Dina C, Dorr M, Elliott P, Felix SB, Fischer K, Fuchsberger C, de
            Geus EJ, Goyette P, Gudnason V, Harris TB, Hartikainen AL, Havulinna
            AS, Heckbert SR, Hicks AA, Hofman A, Holewijn S, Hoogstra-Berends F,
            Hottenga JJ, Jensen MK, Johansson A, Junttila J, Kaab S, Kanon B,
            Ketkar S, Khaw KT, Knowles JW, Kooner AS, Kors JA, Kumari M, Milani
            L, Laiho P, Lakatta EG, Langenberg C, Leusink M, Liu Y, Luben RN,
            Lunetta KL, Lynch SN, Markus MR, Marques-Vidal P, Mateo Leach I,
            McArdle WL, McCarroll SA, Medland SE, Miller KA, Montgomery GW,
            Morrison AC, Muller-Nurasyid M, Navarro P, Nelis M, O'Connell JR,
            O'Donnell CJ, Ong KK, Newman AB, Peters A, Polasek O, Pouta A,
            Pramstaller PP, Psaty BM, Rao DC, Ring SM, Rossin EJ, Rudan D, Sanna
            S, Scott RA, Sehmi JS, Sharp S, Shin JT, Singleton AB, Smith AV,
            Soranzo N, Spector TD, Stewart C, Stringham HM, Tarasov KV,
            Uitterlinden AG, Vandenput L, Hwang SJ, Whitfield JB, Wijmenga C,
            Wild SH, Willemsen G, Wilson JF, Witteman JC, Wong A, Wong Q,
            Jamshidi Y, Zitting P, Boer JM, Boomsma DI, Borecki IB, van Duijn
            CM, Ekelund U, Forouhi NG, Froguel P, Hingorani A, Ingelsson E,
            Kivimaki M, Kronmal RA, Kuh D, Lind L, Martin NG, Oostra BA,
            Pedersen NL, Quertermous T, Rotter JI, van der Schouw YT, Verschuren
            WM, Walker M, Albanes D, Arnar DO, Assimes TL, Bandinelli S, Boehnke
            M, de Boer RA, Bouchard C, Caulfield WL, Chambers JC, Curhan G, Cusi
            D, Eriksson J, Ferrucci L, van Gilst WH, Glorioso N, de Graaf J,
            Groop L, Gyllensten U, Hsueh WC, Hu FB, Huikuri HV, Hunter DJ,
            Iribarren C, Isomaa B, Jarvelin MR, Jula A, Kahonen M, Kiemeney LA,
            van der Klauw MM, Kooner JS, Kraft P, Iacoviello L, Lehtimaki T,
            Lokki ML, Mitchell BD, Navis G, Nieminen MS, Ohlsson C, Poulter NR,
            Qi L, Raitakari OT, Rimm EB, Rioux JD, Rizzi F, Rudan I, Salomaa V,
            Sever PS, Shields DC, Shuldiner AR, Sinisalo J, Stanton AV, Stolk
            RP, Strachan DP, Tardif JC, Thorsteinsdottir U, Tuomilehto J, van
            Veldhuisen DJ, Virtamo J, Viikari J, Vollenweider P, Waeber G, Widen
            E, Cho YS, Olsen JV, Visscher PM, Willer C, Franke L, Erdmann J,
            Thompson JR, Pfeufer A, Sotoodehnia N, Newton-Cheh C, Ellinor PT,
            Stricker BH, Metspalu A, Perola M, Beckmann JS, Smith GD, Stefansson
            K, Wareham NJ, Munroe PB, Sibon OC, Milan DJ, Snieder H, Samani NJ
            and Loos RJ.
  CONSRTM   Global BPgen Consortium; CARDIoGRAM Consortium; PR GWAS Consortium;
            QRS GWAS Consortium; QT-IGC Consortium; CHARGE-AF Consortium
  TITLE     Identification of heart rate-associated loci and their effects on
            cardiac conduction and rhythm disorders
  JOURNAL   Nat. Genet. 45 (6), 621-631 (2013)
   PUBMED   23583979
REFERENCE   6  (residues 1 to 466)
  AUTHORS   van Koppen CJ and Nathanson NM.
  TITLE     Site-directed mutagenesis of the m2 muscarinic acetylcholine
            receptor. Analysis of the role of N-glycosylation in receptor
            expression and function
  JOURNAL   J. Biol. Chem. 265 (34), 20887-20892 (1990)
   PUBMED   2249995
REFERENCE   7
  AUTHORS   van Koppen,C.J. and Nathanson,N.M.
  TITLE     Site-directed mutagenesis of the m2 muscarinic acetylcholine
            receptor. Analysis of the role of N-glycosylation in receptor
            expression and function
  JOURNAL   J. Biol. Chem. 265 (34), 20887-20892 (1990)
   PUBMED   2249995
REFERENCE   8  (residues 1 to 466)
  AUTHORS   Goyal RK.
  TITLE     Muscarinic receptor subtypes. Physiology and clinical implications
  JOURNAL   N. Engl. J. Med. 321 (15), 1022-1029 (1989)
   PUBMED   2674717
  REMARK    Review article
REFERENCE   9  (residues 1 to 466)
  AUTHORS   Ashkenazi A, Ramachandran J and Capon DJ.
  TITLE     Acetylcholine analogue stimulates DNA synthesis in brain-derived
            cells via specific muscarinic receptor subtypes
  JOURNAL   Nature 340 (6229), 146-150 (1989)
   PUBMED   2739737
REFERENCE   10  (residues 1 to 466)
  AUTHORS   Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J and
            Capon DJ.
  TITLE     Distinct primary structures, ligand-binding properties and
            tissue-specific expression of four human muscarinic acetylcholine
            receptors
  JOURNAL   EMBO J. 6 (13), 3923-3929 (1987)
   PUBMED   3443095
REFERENCE   11  (residues 1 to 466)
  AUTHORS   Bonner,T.I., Buckley,N.J., Young,A.C. and Brann,M.R.
  TITLE     Identification of a family of muscarinic acetylcholine receptor
            genes
  JOURNAL   Science 237 (4814), 527-532 (1987)
   PUBMED   3037705
  REMARK    Erratum:[Science 1987 Sep 25;237(4822):237]
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AY034604.2, AF498916.1 and
            AY456129.1.
            This sequence is a reference standard in the RefSeqGene project.
            Summary: The muscarinic cholinergic receptors belong to a larger
            family of G protein-coupled receptors. The functional diversity of
            these receptors is defined by the binding of acetylcholine to these
            receptors and includes cellular responses such as adenylate cyclase
            inhibition, phosphoinositide degeneration, and potassium channel
            mediation. Muscarinic receptors influence many effects of
            acetylcholine in the central and peripheral nervous system. The
            muscarinic cholinergic receptor 2 is involved in mediation of
            bradycardia and a decrease in cardiac contractility. Multiple
            alternatively spliced transcript variants have been described for
            this gene. [provided by RefSeq, Jul 2008].
            Transcript Variant: This variant (4) differs in the 5' UTR compared
            to variant 1. Variants 1 through 8 encode the same protein (isoform
            a).
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: AY034604.2 [ECO:0000332]
            RNAseq introns              :: mixed/partial sample support
            ERS025082, ERS025084 [ECO:0000350]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..466
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="7"
                     /map="7q31-q35"
     Protein         1..466
                     /note="muscarinic M2 receptor; 7TM receptor; cholinergic
                     receptor, muscarinic 2, isoform a; acetylcholine receptor,
                     muscarinic 2"
                     /product="muscarinic acetylcholine receptor M2"
                     /calculated_mol_wt="51584"
     Site            2
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /site_type="glycosylation"
     Site            3
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /site_type="glycosylation"
     Site            6
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /site_type="glycosylation"
     Site            23..45
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          46..440
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            60..80
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            98..119
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            140..162
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            185..207
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          <255..>385
                     /note="S100P-binding protein; pfam15427"
                     /db_xref="CDD:259558"
                     /region_name="S100PBPR"
     Site            389..409
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            424..443
                     /note="propagated from UniProtKB/Swiss-Prot (P08172.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..466
                     /coded_by="NM_000739.2:372..1772"
                     /gene="CHRM2"
                     /gene_synonym="HM2"
                     /db_xref="CCDS:CCDS5843.1"
                     /db_xref="GeneID:1129"
                     /db_xref="HGNC:HGNC:1951"
                     /db_xref="HPRD:00328"
                     /db_xref="MIM:118493"
ORIGIN
        1 mnnstnssnn slaltspykt fevvfivlva gslslvtiig nilvmvsikv nrhlqtvnny
       61 flfslacadl iigvfsmnly tlytvigywp lgpvvcdlwl aldyvvsnas vmnlliisfd
      121 ryfcvtkplt ypvkrttkma gmmiaaawvl sfilwapail fwqfivgvrt vedgecyiqf
      181 fsnaavtfgt aiaafylpvi imtvlywhis rasksrikkd kkepvanqdp vspslvqgri
      241 vkpnnnnmps sddglehnki qngkaprdpv tencvqgeek essndstsvs avasnmrdde
      301 itqdentvst slghskdens kqtcirigtk tpksdsctpt nttvevvgss gqngdekqni
      361 varkivkmtk qpakkkppps rekkvtrtil aillafiitw apynvmvlin tfcapcipnt
      421 vwtigywlcy instinpacy alcnatfkkt fkhllmchyk nigatr
//
